NCT07604415

Brief Summary

Fecal incontinence is a disabling condition that can substantially impair quality of life. This study evaluates whether home-based anal electrical stimulation combined with active voluntary anal sphincter contraction is superior to electrical stimulation alone in patients with fecal incontinence. The study is a prospective, randomized, parallel-group, open-label controlled trial. Participants will be randomized in a 1:1 ratio to either electrical stimulation with synchronized active sphincter contraction or electrical stimulation alone. The primary outcome is the change in Vaizey/St. Mark's Incontinence Score from baseline to week 12. Secondary outcomes include fecal incontinence episodes, quality of life, anorectal manometry parameters, adherence, safety, and sustained response during follow-up.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
36mo left

Started May 2026

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
May 2026May 2029

Study Start

First participant enrolled

May 15, 2026

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

May 17, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 22, 2026

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2029

Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

3 years

First QC Date

May 17, 2026

Last Update Submit

May 17, 2026

Conditions

Keywords

fecal incontinenceanal stimulationpelvic floor training

Outcome Measures

Primary Outcomes (1)

  • Change in Vaizey (St. Mark's) Incontinence Score From Baseline to Week 12

    Mean change in Vaizey (St. Mark's) Incontinence Score between baseline and week 12. The Vaizey score ranges from 0 to 24, with higher scores indicating more severe fecal incontinence symptoms.

    Baseline to Week 12

Secondary Outcomes (9)

  • Change in Weekly Fecal Incontinence Episodes From Baseline to Week 12

    Baseline to Week 12

  • Proportion of Participants Achieving ≥30% Reduction in Vaizey Score at Week 12

    Week 12

  • Sustained Improvement in Vaizey Score at Week 36

    Baseline to Week 36

  • Change in Maximum Squeeze Pressure on High-Resolution Anorectal Manometry

    Baseline to Week 12

  • Change in Resting Anal Pressure on High-Resolution Anorectal Manometry

    Baseline to Week 12

  • +4 more secondary outcomes

Study Arms (2)

Electrical Stimulation + Active Contraction

ACTIVE COMPARATOR

Home-based anal electrical stimulation combined with synchronized active voluntary anal sphincter contraction for 12 weeks

Device: Home-based anal electrical stimulator

Electrical Stimulation Alone

ACTIVE COMPARATOR

Home-based anal electrical stimulation alone without active voluntary sphincter contraction for 12 weeks.

Device: Home-based anal electrical stimulator

Interventions

Home-based anal electrical stimulation delivered using the NeuroTrac Continence device. Stimulation parameters include frequency 40 Hz, pulse width 250 µs, 5 seconds ON and 10 seconds OFF cycles, 1-second ramp-up, session duration 25 minutes, and patient-adjusted intensity up to the maximum tolerable level without pain.

Electrical Stimulation + Active ContractionElectrical Stimulation Alone

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Signed informed consent
  • Age ≥18 years
  • Diagnosis of fecal incontinence (urge, passive, or mixed type) with at least 1 episode of involuntary stool leakage requiring hygiene intervention or underwear change per month for ≥3 months
  • Vaizey (St. Mark's) Incontinence Score ≥8
  • Ability to understand study procedures and comply with the 12-week home intervention
  • Willingness to attend all study visits and assessments
  • Stable medical management for fecal incontinence for at least 4 weeks prior to enrollment

You may not qualify if:

  • Complete spinal cord injury above the conus medullaris
  • Active inflammatory bowel disease flare requiring systemic therapy or not in clinical remission
  • Rectal prolapse requiring surgical intervention
  • Severe symptomatic hemorrhoids interfering with anorectal assessments or device use
  • Active anal fissure or perianal fistula
  • Active colorectal cancer or history of colorectal cancer within 5 years
  • Colorectal surgery within the previous 6 months
  • Pregnancy or planned pregnancy during study participation
  • Implanted cardiac pacemaker or defibrillator
  • Other implanted electrical devices contraindicating electrical stimulation
  • Previous specialized pelvic floor physiotherapy, biofeedback therapy, EMG-guided rehabilitation, or anal electrical stimulation within 3 months prior to randomization
  • Cognitive impairment preventing understanding of study procedures or informed consent
  • Uncontrolled severe diarrhea (\>5 liquid stools/day)
  • Anal stenosis preventing probe insertion
  • Severe anal sphincter defect (\>120° on ultrasound) requiring surgical repair
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinic of Internal Medicine- Gastroenterology, University Hospital Martin

Martin, 03601, Slovakia

RECRUITING

MeSH Terms

Conditions

Fecal Incontinence

Condition Hierarchy (Ancestors)

Rectal DiseasesIntestinal DiseasesGastrointestinal DiseasesDigestive System Diseases

Study Officials

  • Peter Liptak, MD, PhD

    Clinic of Internal Medicine- Gastroenterology, University Hospital Martin, Jessenous Faculty of Medicine in Martin, Comenius University, Slovakia

    STUDY DIRECTOR

Central Study Contacts

Peter Liptak, MD, PHD

CONTACT

Adam Lukac, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Due to the nature of the intervention, neither participants nor investigators can be blinded. Participants are aware whether they perform active voluntary sphincter contractions during stimulation, and investigators are involved in patient training and outcome assessments.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomized in a 1:1 ratio to receive either home-based anal electrical stimulation combined with active voluntary anal sphincter contraction or electrical stimulation alone. Both interventions will be performed for 12 weeks using identical stimulation parameters.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Consultant Gastroenterologist and clinical researcher

Study Record Dates

First Submitted

May 17, 2026

First Posted

May 22, 2026

Study Start

May 15, 2026

Primary Completion (Estimated)

May 1, 2029

Study Completion (Estimated)

May 1, 2029

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the reported study results may be shared upon reasonable request to the principal investigator following publication of the primary results. Data sharing will be considered for methodologically sound research proposals and in accordance with institutional policies, ethical approval requirements, and applicable data protection regulations (including GDPR).

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 6 months after publication of the primary study results and ending 5 years after publication
Access Criteria
Access will be provided to qualified researchers whose proposed use of the data has been approved by the study investigators and relevant institutional authorities. A data access agreement may be required.

Locations